MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Prevalence of neurogenic orthostatic hypotension in the idiopathic Parkinson Progression Marker Initiative cohort.

    P. Beach, J. Mckay (Atlanta, USA)

    Objective: To assess prevalence of neurogenic and peripheral orthostatic hypotension (nOH/pOH) in the PPMI (https://www.ppmi-info.org) idiopathic Parkinson disease (PD) cohort and to examine whether nOH,…
  • MDS Virtual Congress 2021

    Is dopamine replacement therapy an addictive drug?

    V. Fleury, E. Pirondini, C. Provins, D. Benis, D. Vandeville, P. Krack (Geneva, Switzerland)

    Objective: To identify common clinical and imaging abnormalities in Parkinson's disease patients and heroin-dependent patients compared with healthy controls in order to better understand the pathophysiology…
  • MDS Virtual Congress 2021

    Data-driven prediction of fatigue in Parkinson’s disease patients

    DG. Lee, M. Mirian, L. Adrian, A. Yu, S. Neilson, K. Sundvick, E. Golz, L. Folger, S. Appel-Cresswell (Vancouver, Canada)

    Objective: The overall aim of this study is to identify which items of the Fatigue Severity Scale (FSS) best predict clinically significant fatigue in male…
  • MDS Virtual Congress 2021

    Dopamine dysregulation syndrome in Parkinson’s disease after COVID-19. Case report.

    A. Nikitina, D. Degterev (Moscow, Russian Federation)

    Objective: To describe a case of a man with Parkinson’s disease (PD), who was developed dopamine dysregulation syndrome (DDS) after COVID-19. Background: Parkinson’s disease is…
  • MDS Virtual Congress 2021

    The effect of deep brain stimulation on impulse control related disorders in Parkinson’s disease – a retrospective review of 137 patients

    H. Shepherd, S. Healy, N. Mooney, A. da Costa, M. Bonello, D. Damodaran, J. Panicker, B. Hammersley, J. Somerset, P. Eldridge, J. Osman-Farah, S. Alusi, A. Macerollo (Liverpool, United Kingdom)

    Objective: To assess the effect of deep brain stimulation on impulse control related disorders on patients with Parkinson’s Disease (PD) at our centre. Background: Approximately…
  • MDS Virtual Congress 2021

    Conception of a sensor- and home-based measurement of camptocormia

    R. Wolke, K. Naderi Beni, H. Wolframm, R. Rieger, N. Margraf (Kiel, Germany)

    Objective: This conception aims to outline the medical and technical requirements and a possible setup for an inertial-measurement-unit (IMU) quantifying camptocormia over a longer period…
  • MDS Virtual Congress 2021

    HbA1c correlates with motor and cognitive outcome scores in patients with Parkinson’s disease and type 2 diabetes.

    B. Huxford, T. Haque, A. Joseph, C. Simonet, D. Gallagher, C. Budu, R. Dobson, A. Noyce (London, United Kingdom)

    Objective: The objective of this study was to investigate the relationship between glycated haemoglobin (HbA1c) levels in blood and clinical outcomes (MDS-UPDRS III, MDS-UPDRS IV,…
  • MDS Virtual Congress 2021

    Do Parkinson’s disease medications have an effect on gut microbiome? A case-control study

    P. Zhang, P. Huang, Y. Qian, X. Yang, Y. He, J. Du, G. Li, S. Cui, S. Xu, J. Liu, Y. Lin, Y. Fu, G. He, Z. Zhang, Q. Xiao, S. Chen (Shanghai, China)

    Objective: To investigate the difference in the gut microbiota between drug-naïve and medicated PD patients and focus on the association between gut microbiota and anti-PD medications. Background:…
  • MDS Virtual Congress 2021

    Characterization of a mouse model of PDE10A-related autosomal-dominant movement disorder.

    N. Marotta, N. Mencacci, M. Pereira Luppi, R. Awatramani, D. Krainc (Chicago, USA)

    Objective: To characterize a newly generated mouse model of the movement disorder caused by PDE10A pathogenic mutation F300L. Background: Phosphodiesterase 10A (PDE10A) is a striatal…
  • MDS Virtual Congress 2021

    Conceptualization of Gait Assessment Model Using Auditory and Visual Cues

    O. Dada (Ibadan, Nigeria)

    Objective: The need for a low resource gait assessment model has prompted the researcher to conceptualize a study on how a commonly used children footwear…
  • « Previous Page
  • 1
  • …
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley